Industrial Hemp Operations Expansion Continues To
Solidify Itself As An Agricultural Commodity As Reports Show Sales
North Of $500Mil Annually
Coral Springs, FL -- August 23, 2016 -- InvestorsHub NewsWire
-- With approved pilot programs and increased research
funding, the industrial hemp sector aims to continue its success
both financially and as a whole as it moves towards greater
acceptance in society. Precise data are not available on the size
of the U.S. market for hemp-based products, but according to
Federation of American Scientists (FAS.org) current industry estimates report annual sales at
more than $580 million annually. Hemp, cannabis and legal
marijuana advancements are drawing more and more legit companies
into the industry as the market has shown to keep close watch of
Green Cures & Botanical Distribution Inc. (OTC
Pink: GRCU), Medical Marijuana, Inc. (OTC
Pink: MJNA), Greengro Technologies, Inc. (OTC
Pink: GRNH), Hemp, Inc. (OTC
Pink: HEMP) and PharmaCyte Biotech, Inc. (OTCQB:
PMCB).
Green Cures & Botanical Distribution Inc. (OTC:
GRCU), a medical marijuana and industrial hemp products
innovator announced today that the company has finalized and closed
the land lease deal to lease 20 acres of agricultural land in the
Adelanto, CA area.
GRCU is well on its way to be a part of the major movement in
the medical marijuana sector in the cultivation area. Now that the
company has closed the leasing agreement, the company can lock down
and finalize the agreement with an already established licensed
grower.
Read the full GRCU Press Release at: http://financialnewsmedia.com/profiles/grcu.html
As previously stated, high profile celebrities have shown major
interest to cultivate cannabis in the city of Adelanto and GRCU
will be established as one of the first one-stop-shops for this
huge economic opportunity alongside of these well-known
entertainment celebrities. Marijuana, although legal in only a few
states in the US, is one of the most popular intermediaries for
Americans, who, in 2015 spent more on legal marijuana ($3.4B) than
they did on Oreos ($711M). As the herbs illicit reputation is shed,
it will become an ingredient engrained in our lives like any other
legal and socially acceptable go-between.
In other news and trading activity from around the industry of
note in the markets:
Medical Marijuana, Inc. (OTC:
MJNA), the first-ever publicly traded cannabis company in the
United States, announced that at The San Francisco Money Show's
Cannabis Investing Symposium, which the Company is sponsoring,
Medical Marijuana, Inc. CEO Dr. Stuart Titus will speak to
investors about current global cannabis industry trends, investment
opportunities and how the Company's diversified portfolio of
cannabis companies and brands are capitalizing on the current
cannabis revolution.
Greengro Technologies, Inc. (OTC:
GRNH) a world-class provider of eco-friendly green
technologies, recently announced this month that the Company's new
business division, CBDVentures, plans for its new selection of
hemp-infused fruit flavored CBD nectars. The Company's CBD Energy
Nectar Beverage line is all natural and enhanced with hemp,
guarana, ginseng, and a sweet savor of robust authenticity. The
nectars deliver a tasty blast of fruit flavor coupled with an
energy boost specially formulated to create a gratification that
fully lives up to the very definition of its name; Amrita:
"Immortality" and Nectar: "The flavored drink of the gods".
Hemp, Inc. (OTC:
HEMP) executives announced that its wholly owned subsidiary,
Industrial Hemp Manufacturing, LLC, sponsored the "hempcentric"
festival, HEMP X, this past weekend at the Highland Brewing Company
in Asheville, North Carolina. The family-friendly free event,
hosted Asheville-area farmers, entrepreneurs, and other small
business owners in an effort to highlight the economic benefits of
growing industrial hemp while educating Americans on the importance
of hemp and the multiple uses and benefits of industrial hemp.
PharmaCyte Biotech, Inc. (OTC:
PMCB) closed up at $0.0415 on high volume trading activity of
over 13.9Million shares traded by the market close. PMCB announced
back in July that a recently published scientific article supports
PharmaCytes ongoing research efforts that concern medical uses for
constituents of Cannabis known as cannabinoids.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party
publisher and news dissemination service provider, which
disseminates electronic information through multiple online media
channels. FNMG is NOT affiliated in any manner with any
company mentioned herein. FNMG and its affiliated companies
are a news dissemination solutions provider and are NOT a
registered broker/dealer/analyst/adviser, holds no investment
licenses and may NOT sell, offer to sell or offer to buy any
security. FNMG's market updates, news alerts and corporate
profiles are NOT a solicitation or recommendation to buy, sell or
hold securities. The material in this release is intended to
be strictly informational and is NEVER to be construed or
interpreted as research material. All readers are strongly
urged to perform research and due diligence on their own and
consult a licensed financial professional before considering any
level of investing in stocks. All material included herein is
republished content and details which were previously disseminated
by the companies mentioned in this release. FNMG is not
liable for any investment decisions by its readers or
subscribers. Investors are cautioned that they may lose all
or a portion of their investment when investing in stocks.
For current services performed FNMG has been compensated three
thousand nine hundred dollars for news coverage of the current
press release issued by Green Cures & Botanical Distribution
Inc. by a non-affiliated third party. FNMG HOLDS NO SHARES OF
ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words
such as "may", "future", "plan" or "planned", "will" or "should",
"expected," "anticipates", "draft", "eventually" or "projected".
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company's annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and FNMG undertakes no
obligation to update such statements.
Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
Phone: (954)345-0611
URL: www.financialnewsmedia.com
Source: FN Media Group
